Catalent, Inc.

Catalent, Inc. is a globally recognized Contract Development and Manufacturing Organization (CDMO) specializing in drug development, biologics manufacturing, advanced drug delivery technologies, and commercial pharmaceutical production. Founded in 2007 as an independent company (with roots tracing back several decades through Cardinal Health’s pharmaceutical technologies business), Catalent is headquartered in Somerset, New Jersey, USA, and serves pharmaceutical, biotechnology, and consumer health companies worldwide.

Catalent provides comprehensive services including formulation development, clinical supply, biologics manufacturing, sterile fill-finish, oral solid dosage manufacturing, softgel technologies, gene therapy support, vaccine production, and commercial manufacturing. The company is particularly known for its expertise in biologics, cell and gene therapies, and advanced oral drug delivery systems.

With more than 50 manufacturing and development facilities across North America, Europe, Asia-Pacific, and Latin America, Catalent maintains rigorous compliance with global regulatory standards established by the US FDA, EMA, MHRA, PMDA, and other international health authorities. The company continues to invest in digital manufacturing, automation, sustainability, and next-generation pharmaceutical technologies to support complex drug development programs.

Through its broad scientific expertise, global manufacturing infrastructure, and commitment to quality, Catalent has become one of the pharmaceutical industry’s leading outsourcing partners for innovative medicines.